Product review · Updated 2026-10-14
Dr. Anna Balance: a cream declaration that belongs in the hormone conversation
Balance lists progesterone and pregnenolone. Its concentration gaps, skincare claims and one-time versus recurring prices deserve separate questions.
Public-source editorial review. No clinician sign-off, firsthand product testing or individual assessment claimed.
Balance’s wild-yam name does not tell the whole ingredient story. The official declaration for Dr. Anna Cabeca’s cream names progesterone and pregnenolone, alongside other skincare ingredients. Those details belong in any discussion of the product, particularly when a reader is already considering facial estriol or another hormone-containing preparation.
On October 14, 2026, the official offer showed $54.95 for a one-time order and $47.26 for recurring deliveries. This review did not involve a purchase, laboratory analysis or medical assessment. It identifies questions about the declared formula and the selected order, without supplying a dosing plan or a recommendation to combine hormone products.
Questions in this article
What does the botanical origin explain, and what does it not?
The seller describes laboratory conversion when explaining the wild-yam source of progesterone. The final declaration explicitly names progesterone and pregnenolone. It also includes Tripeptide-29, emollient ingredients and botanical materials, including lavender and lemongrass entries. The cream should not be summarized as an unmodified yam extract or hormone-free moisturizer. Source 1
The medication-list guide encourages identifying every preparation rather than relying only on a brand’s category name. A peptide highlight does not make the hormonal ingredients disappear, and a plant source does not establish a delivered dose. The full label is the useful starting record for a conversation about what is being considered.
Which concentration and exposure questions remain unanswered?
This review did not verify a concentration for progesterone or pregnenolone, a measured amount per pump or an independently appraised absorption study of the complete marketed cream. The missing details matter because ingredient presence alone cannot establish how much reaches the skin or a person’s circulation. Source 1
The manufacturer states that the product may influence hormones and recommends discussion with a healthcare provider. That caution should stay beside the appearance-related language. Our blood-level claims guide addresses the broader need to distinguish topical use from assumptions about systemic exposure; it is not a pharmacokinetic study of Balance.
A container size or suggested application count cannot answer an absorption question. We do not turn those retail details into a medical schedule, recommend a body site or describe a hormone cycle. Those decisions require an individual assessment and reliable information about the actual preparation, beyond what a general sales page establishes.
Does skincare positioning show that the formula is approved?
FDA explains that intended use and claims help determine whether a product is a cosmetic or a drug. A cream’s retail category is not an approval record for a hormonal effect, nor does it establish that systemic effects are impossible. We did not verify FDA approval of the finished Balance preparation. Source 2
The facial estriol versus menopause-treatment article keeps hormone identities and uses distinct. Progesterone and pregnenolone should not be treated as interchangeable with estriol. Clinical findings about a different hormone product, concentration or vehicle cannot automatically fill the evidence gaps for this particular cream.
A testimonial can describe a person’s reported experience without establishing cause, a typical effect or suitability for another reader. This publication has no independent measurements of benefit to add. The declaration supports identification of the preparation, while the clinical implications remain a separate question.
What does the lower displayed price require?
The $54.95 amount described a one-time order. The $47.26 selections involved recurring deliveries every two or three months. A delivery interval is a commercial arrangement; it should not be interpreted as an application instruction, a validated treatment duration or proof of how long one container will last for an individual. Source 1
The page also presented a $6.99 priority option. That service is not evidence of access to a clinician, rapid medical advice or a confirmed clinical review time. We did not complete checkout or test a subscription change, so the final order total and cancellation experience remain unverified.
Keep the planned renewal date distinct from the date a container was opened. A delivery choice does not establish product stability after opening, and neither date supplies missing concentration or absorption information.
What does the guarantee actually cover?
The product page promotes a sixty-day guarantee and describes US-only availability. This review did not independently inspect complete eligibility conditions sufficient to confirm a refund after opening, repayment of shipping or the rules for a later subscription shipment. Those limits should not be hidden behind an unconditional satisfaction statement. Source 1
If the promise affects the decision, ask for its written terms and identify the date that starts the period. Keep the selected purchase type, delivery record and any return instructions. The publication did not contact support or verify processing speed, and commercial service terms cannot settle the separate medical questions about the hormonal ingredients.
Which record should accompany a professional discussion?
The complete declaration, verified concentrations if supplied, current medicines and the reason for considering the cream are relevant starting information. The prescription-question guide supports keeping unresolved details explicit rather than assuming a retail description supplies an individualized assessment.
AAD advice about noticing skin reactions to a new product does not determine whether hormonal exposure is appropriate. A comfortable skin sensation would not prove absent systemic absorption, and irritation would not by itself quantify a hormone dose. Balance’s public record helps identify named ingredients and order choices; it does not establish personal suitability or equivalence to prescribed estriol. Source 3
The source record
- Wild Yam Cream for Menopause | Balance by Dr. Anna Cabeca ↗Official product or purchase terms · Accessed 2026-10-14
- Cosmetics Labeling Claims | FDA ↗Clinical context · Accessed 2026-10-14
- How to test skin care products ↗Clinical context · Accessed 2026-10-14